Twin Lakes Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,000
Closed -$261K 223
2024
Q4
$261K Hold
1,000
0.17% 74
2024
Q3
$322K Hold
1,000
0.21% 64
2024
Q2
$312K Hold
1,000
0.21% 65
2024
Q1
$284K Hold
1,000
0.19% 69
2023
Q4
$288K Hold
1,000
0.2% 67
2023
Q3
$269K Hold
1,000
0.2% 68
2023
Q2
$222K Hold
1,000
0.16% 76
2023
Q1
$242K Hold
1,000
0.18% 72
2022
Q4
$263K Hold
1,000
0.2% 70
2022
Q3
$225K Hold
1,000
0.18% 77
2022
Q2
$243K Hold
1,000
0.18% 65
2022
Q1
$242K Hold
1,000
0.14% 88
2021
Q4
$225K Hold
1,000
0.12% 89
2021
Q3
$213K Hold
1,000
0.13% 89
2021
Q2
$244K Hold
1,000
0.14% 76
2021
Q1
$249K Hold
1,000
0.15% 73
2020
Q4
$230K Buy
+1,000
New +$231K 0.16% 73

Other funds holding AMGN

Twin Lakes Capital Management's AMGN Position: Q1 2025 in Review

Twin Lakes Capital Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,000 shares — an estimated $261K sold.

Twin Lakes Capital Management first reported a position in AMGN in Q4 2020 and held it in 17 quarters. The position peaked at $322K in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Twin Lakes Capital Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Twin Lakes Capital Management sold 1,000 Amgen shares in Q1 2025, an estimated $261K.
  • Twin Lakes Capital Management first reported a position in Amgen in Q4 2020 and held it in 17 quarters.
  • Twin Lakes Capital Management's Amgen position peaked at $322K in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Twin Lakes Capital Management's 13F filing for Q1 2025, filed 23 May 2025.